Vets Plus Inc., the manufacturer of FLEX Rx, will now also be the distributer of the product in over-the-counter (OTC) channels. The company has expanded its licensing agreement with ProLabs to incorporate the manufacturing and selling of its FLEX Rx joint products.
FLEX Rx chewable tablets offer a specific formulation to support joint health and is intended as a substitute for glucosamine and chondroitin, two common supplements suggested by veterinarians when joint issues arise in dogs. In a multi-clinical study, FLEX Rx proved to be more effective than glucosamine and chondroitin for supporting joint function and mobility.
Vets Plus has been currently manufacturing FLEX Rx; with this agreement, Vets Plus will become the exclusive manufacturer and OTC distributor for the product as well.